Enhance collaboration and cross-fertilization of ideas and approaches
among this widely dispersed community.
2. Provide opportunities for young immunotherapists to meet the
?giants? in the field and thus enhance their careers.
3. Provide the seeds for a collaborative network that would eventually
represent a consortium of individuals working in this field, albeit
focused on different pediatric tumors.
4. Bring together the community to address regulatory challenges in
developing cell products for immune based therapy which will improve
the efficiency of developing protocols which are acceptable to the FDA.
Immunotherapy in Pediatric Oncology: Progress and Challenges